25 XP   0   0   10

Bluebird bio Inc
Buy, Hold or Sell?

Let's analyse Bluebird bio Inc together

PenkeI guess you are interested in Bluebird bio Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Bluebird bio Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Bluebird bio Inc

I send you an email if I find something interesting about Bluebird bio Inc.

Quick analysis of Bluebird bio Inc (30 sec.)










What can you expect buying and holding a share of Bluebird bio Inc? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
10.0%

What is your share worth?

Current worth
$1.02
Expected worth in 1 year
$-2.67
How sure are you?
70.0%

+ What do you gain per year?

Total Gains per Share
$-3.69
Return On Investment
-362.0%

For what price can you sell your share?

Current Price per Share
$1.02
Expected price per share
$0.8618 - $1.6599
How sure are you?
50%

1. Valuation of Bluebird bio Inc (5 min.)




Live pricePrice per Share (EOD)

$1.02

Intrinsic Value Per Share

$-26.72 - $6.58

Total Value Per Share

$-25.70 - $7.60

2. Growth of Bluebird bio Inc (5 min.)




Is Bluebird bio Inc growing?

Current yearPrevious yearGrowGrow %
How rich?$196.3m$374.2m-$177.9m-90.6%

How much money is Bluebird bio Inc making?

Current yearPrevious yearGrowGrow %
Making money-$266.5m-$562.6m$296m111.1%
Net Profit Margin-7,411.1%-15,364.2%--

How much money comes from the company's main activities?

3. Financial Health of Bluebird bio Inc (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#255 / 1007

Most Revenue
#388 / 1007

Most Profit
#1002 / 1007

Most Efficient
#923 / 1007

What can you expect buying and holding a share of Bluebird bio Inc? (5 min.)

Welcome investor! Bluebird bio Inc's management wants to use your money to grow the business. In return you get a share of Bluebird bio Inc.

What can you expect buying and holding a share of Bluebird bio Inc?

First you should know what it really means to hold a share of Bluebird bio Inc. And how you can make/lose money.

Speculation

The Price per Share of Bluebird bio Inc is $1.02. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Bluebird bio Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Bluebird bio Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $1.02. Based on the TTM, the Book Value Change Per Share is $-0.92 per quarter. Based on the YOY, the Book Value Change Per Share is $-5.09 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Bluebird bio Inc.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-1.38-135.6%-1.38-135.6%-4.25-416.8%-3.16-310.3%-2.02-197.9%
Usd Book Value Change Per Share-0.92-90.5%-0.92-90.5%-5.09-498.9%-1.48-145.2%0.1312.8%
Usd Dividend Per Share0.000.0%0.000.0%0.9088.7%0.1817.7%0.098.9%
Usd Total Gains Per Share-0.92-90.5%-0.92-90.5%-4.18-410.2%-1.30-127.4%0.2221.7%
Usd Price Per Share6.92-6.92-9.99-49.40-66.35-
Price to Earnings Ratio-5.00--5.00--2.35--15.33--82.05-
Price-to-Total Gains Ratio-7.50--7.50--2.39-30.79-93.29-
Price to Book Ratio6.79-6.79-5.14-8.28-15.34-
Price-to-Total Gains Ratio-7.50--7.50--2.39-30.79-93.29-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share1.02
Number of shares980
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.18
Usd Book Value Change Per Share-0.92-1.48
Usd Total Gains Per Share-0.92-1.30
Gains per Quarter (980 shares)-904.71-1,273.98
Gains per Year (980 shares)-3,618.83-5,095.93
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-3619-3629709-5805-5106
20-7238-72481418-11610-10202
30-10857-108672127-17415-15298
40-14475-144862836-23219-20394
50-18094-181053545-29024-25490
60-21713-217244254-34829-30586
70-25332-253434962-40634-35682
80-28951-289625671-46439-40778
90-32570-325816380-52244-45874
100-36188-362007089-58048-50970

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%0.05.00.00.0%0.010.00.00.0%0.012.00.00.0%
Book Value Change Per Share0.01.00.00.0%1.02.00.033.3%2.03.00.040.0%7.03.00.070.0%7.05.00.058.3%
Dividend per Share0.00.01.00.0%1.00.02.033.3%1.00.04.020.0%1.00.09.010.0%1.00.011.08.3%
Total Gains per Share0.01.00.00.0%1.02.00.033.3%2.03.00.040.0%7.03.00.070.0%7.05.00.058.3%

Fundamentals of Bluebird bio Inc

About Bluebird bio Inc

bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include ZYNTEGLO (betibeglogene autotemcel) for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell disease (SCD); and SKYSONA (elivaldogene autotemcel) to treat cerebral adrenoleukodystrophy. The company's clinical development programs include HGB-205, HGB-206, and HGB-210 to evaluate the safety and efficacy of lovo-cel in the treatment of patients with SCD; and HGB-204, HGB-205, HGB-207, and HGB-212 to evaluate the safety and efficacy of beti-cel in the treatment of patients with ß-thalassemia. It has license agreement with Orchard Therapeutics Limited. The company was formerly known as Genetix Pharmaceuticals, Inc., and changed its name to bluebird bio, Inc. in September 2010. bluebird bio, Inc. was incorporated in 1992 and is headquartered in Somerville, Massachusetts.

Fundamental data was last updated by Penke on 2024-05-02 12:29:06.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is just able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is overpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Bluebird bio Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Bluebird bio Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Bluebird bio Inc to the Biotechnology industry mean.
  • A Net Profit Margin of -7,411.1% means that $-74.11 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Bluebird bio Inc:

  • The MRQ is -7,411.1%. The company is making a huge loss. -2
  • The TTM is -7,411.1%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-7,411.1%TTM-7,411.1%0.0%
TTM-7,411.1%YOY-15,364.2%+7,953.1%
TTM-7,411.1%5Y-5,161.5%-2,249.6%
5Y-5,161.5%10Y-3,253.8%-1,907.7%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-7,411.1%-184.9%-7,226.2%
TTM-7,411.1%-209.9%-7,201.2%
YOY-15,364.2%-267.4%-15,096.8%
5Y-5,161.5%-417.7%-4,743.8%
10Y-3,253.8%-593.8%-2,660.0%
1.1.2. Return on Assets

Shows how efficient Bluebird bio Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Bluebird bio Inc to the Biotechnology industry mean.
  • -48.0% Return on Assets means that Bluebird bio Inc generated $-0.48 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Bluebird bio Inc:

  • The MRQ is -48.0%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -48.0%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-48.0%TTM-48.0%0.0%
TTM-48.0%YOY-94.8%+46.7%
TTM-48.0%5Y-49.6%+1.6%
5Y-49.6%10Y-32.6%-17.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-48.0%-12.7%-35.3%
TTM-48.0%-12.2%-35.8%
YOY-94.8%-11.2%-83.6%
5Y-49.6%-13.4%-36.2%
10Y-32.6%-14.9%-17.7%
1.1.3. Return on Equity

Shows how efficient Bluebird bio Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Bluebird bio Inc to the Biotechnology industry mean.
  • -135.8% Return on Equity means Bluebird bio Inc generated $-1.36 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Bluebird bio Inc:

  • The MRQ is -135.8%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -135.8%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-135.8%TTM-135.8%0.0%
TTM-135.8%YOY-150.3%+14.6%
TTM-135.8%5Y-84.5%-51.2%
5Y-84.5%10Y-52.0%-32.5%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-135.8%-16.3%-119.5%
TTM-135.8%-15.6%-120.2%
YOY-150.3%-13.9%-136.4%
5Y-84.5%-18.7%-65.8%
10Y-52.0%-19.6%-32.4%

1.2. Operating Efficiency of Bluebird bio Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Bluebird bio Inc is operating .

  • Measures how much profit Bluebird bio Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Bluebird bio Inc to the Biotechnology industry mean.
  • An Operating Margin of -7,981.4% means the company generated $-79.81  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Bluebird bio Inc:

  • The MRQ is -7,981.4%. The company is operating very inefficient. -2
  • The TTM is -7,981.4%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-7,981.4%TTM-7,981.4%0.0%
TTM-7,981.4%YOY-16,136.3%+8,154.9%
TTM-7,981.4%5Y-5,451.0%-2,530.4%
5Y-5,451.0%10Y-3,419.6%-2,031.4%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-7,981.4%-336.0%-7,645.4%
TTM-7,981.4%-221.6%-7,759.8%
YOY-16,136.3%-281.8%-15,854.5%
5Y-5,451.0%-440.7%-5,010.3%
10Y-3,419.6%-567.1%-2,852.5%
1.2.2. Operating Ratio

Measures how efficient Bluebird bio Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 79.44 means that the operating costs are $79.44 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Bluebird bio Inc:

  • The MRQ is 79.441. The company is inefficient in keeping operating costs low. -1
  • The TTM is 79.441. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ79.441TTM79.4410.000
TTM79.441YOY155.317-75.876
TTM79.4415Y53.775+25.666
5Y53.77510Y38.898+14.877
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ79.4413.110+76.331
TTM79.4413.238+76.203
YOY155.3173.647+151.670
5Y53.7755.416+48.359
10Y38.8987.364+31.534

1.3. Liquidity of Bluebird bio Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Bluebird bio Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 1.56 means the company has $1.56 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Bluebird bio Inc:

  • The MRQ is 1.556. The company is able to pay all its short-term debts. +1
  • The TTM is 1.556. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ1.556TTM1.5560.000
TTM1.556YOY2.200-0.644
TTM1.5565Y4.914-3.358
5Y4.91410Y8.140-3.226
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.5563.800-2.244
TTM1.5564.158-2.602
YOY2.2005.275-3.075
5Y4.9146.081-1.167
10Y8.1406.408+1.732
1.3.2. Quick Ratio

Measures if Bluebird bio Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Bluebird bio Inc to the Biotechnology industry mean.
  • A Quick Ratio of 2.03 means the company can pay off $2.03 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Bluebird bio Inc:

  • The MRQ is 2.026. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 2.026. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ2.026TTM2.0260.000
TTM2.026YOY3.571-1.545
TTM2.0265Y8.977-6.951
5Y8.97710Y12.415-3.438
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ2.0263.419-1.393
TTM2.0263.909-1.883
YOY3.5715.230-1.659
5Y8.9776.030+2.947
10Y12.4156.388+6.027

1.4. Solvency of Bluebird bio Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Bluebird bio Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Bluebird bio Inc to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.65 means that Bluebird bio Inc assets are financed with 64.6% credit (debt) and the remaining percentage (100% - 64.6%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Bluebird bio Inc:

  • The MRQ is 0.646. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.646. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.646TTM0.6460.000
TTM0.646YOY0.370+0.276
TTM0.6465Y0.334+0.312
5Y0.33410Y0.263+0.071
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.6460.349+0.297
TTM0.6460.340+0.306
YOY0.3700.275+0.095
5Y0.3340.366-0.032
10Y0.2630.389-0.126
1.4.2. Debt to Equity Ratio

Measures if Bluebird bio Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Bluebird bio Inc to the Biotechnology industry mean.
  • A Debt to Equity ratio of 182.6% means that company has $1.83 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Bluebird bio Inc:

  • The MRQ is 1.826. The company is just able to pay all its debts with equity.
  • The TTM is 1.826. The company is just able to pay all its debts with equity.
Trends
Current periodCompared to+/- 
MRQ1.826TTM1.8260.000
TTM1.826YOY0.587+1.240
TTM1.8265Y0.652+1.174
5Y0.65210Y0.451+0.201
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.8260.393+1.433
TTM1.8260.410+1.416
YOY0.5870.341+0.246
5Y0.6520.444+0.208
10Y0.4510.477-0.026

2. Market Valuation of Bluebird bio Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Bluebird bio Inc generates.

  • Above 15 is considered overpriced but always compare Bluebird bio Inc to the Biotechnology industry mean.
  • A PE ratio of -5.00 means the investor is paying $-5.00 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Bluebird bio Inc:

  • The EOD is -0.737. Based on the earnings, the company is expensive. -2
  • The MRQ is -5.003. Based on the earnings, the company is expensive. -2
  • The TTM is -5.003. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.737MRQ-5.003+4.266
MRQ-5.003TTM-5.0030.000
TTM-5.003YOY-2.350-2.653
TTM-5.0035Y-15.326+10.323
5Y-15.32610Y-82.052+66.726
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.737-2.302+1.565
MRQ-5.003-2.570-2.433
TTM-5.003-2.776-2.227
YOY-2.350-3.945+1.595
5Y-15.326-6.409-8.917
10Y-82.052-6.543-75.509
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Bluebird bio Inc:

  • The EOD is -0.537. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -3.643. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -3.643. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.537MRQ-3.643+3.106
MRQ-3.643TTM-3.6430.000
TTM-3.643YOY-2.923-0.719
TTM-3.6435Y-18.076+14.433
5Y-18.07610Y-50.767+32.691
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.537-3.025+2.488
MRQ-3.643-3.437-0.206
TTM-3.643-3.598-0.045
YOY-2.923-5.240+2.317
5Y-18.076-8.339-9.737
10Y-50.767-8.910-41.857
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Bluebird bio Inc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 6.79 means the investor is paying $6.79 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Bluebird bio Inc:

  • The EOD is 1.001. Based on the equity, the company is underpriced. +1
  • The MRQ is 6.793. Based on the equity, the company is overpriced. -1
  • The TTM is 6.793. Based on the equity, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD1.001MRQ6.793-5.792
MRQ6.793TTM6.7930.000
TTM6.793YOY5.145+1.649
TTM6.7935Y8.277-1.483
5Y8.27710Y15.335-7.059
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD1.0011.998-0.997
MRQ6.7932.069+4.724
TTM6.7932.095+4.698
YOY5.1452.786+2.359
5Y8.2773.617+4.660
10Y15.3354.038+11.297
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Bluebird bio Inc.

3.1. Institutions holding Bluebird bio Inc

Institutions are holding 65.141% of the shares of Bluebird bio Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31State Street Corporation7.19390.00091386571912006039.4796
2023-12-31BlackRock Inc4.66060.000389830011545881.751
2023-12-31Vanguard Group Inc4.55290.00038775379315791956.2161
2023-12-31Granahan Investment Management Inc..4.19090.36828077697293991957.2216
2023-09-30Partner Fund Management LP3.13420.86516040934-1244187-17.0785
2023-12-31Pictet Asset Manangement SA2.95080.0087568733453978110.4862
2023-09-30TANG CAPITAL MANAGEMENT LLC2.22211.83724282827-3100000-41.9893
2023-12-31NORGES BANK2.0730.0013995600395820910585.994
2023-12-31Millennium Management LLC1.77110.00234136123091425959.5126
2023-12-31Palo Alto Investors, LLC1.72940.4145333333333333330
2023-12-31Ghisallo Capital Management LLC1.63430.4494315000031500000
2023-12-31Dimensional Fund Advisors, Inc.1.5540.00122995274130669177.3839
2023-12-31Two Sigma Investments LLC1.51020.0092291081229108120
2023-12-31Ameriprise Financial Inc1.42970.0011275570045322719.6844
2023-12-31Renaissance Technologies Corp1.3690.005626387002163800455.6328
2023-12-31Goldman Sachs Group Inc1.32470.000325531721792398235.6019
2023-12-31Bleichroeder LP1.29710.766725000001600000177.7778
2023-12-31FMR Inc1.2330.0003237656622113451338.4164
2023-12-31Geode Capital Management, LLC1.22950.000323696841481906.6707
2023-12-31Hudson Bay Capital Management LP1.13280.019121834371528437233.3492
Total 48.19324.751492888781+31296490+33.7%

3.2. Funds holding Bluebird bio Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-03-31Vanguard Total Stock Mkt Idx Inv3.14290.0005605776693250.1542
2024-03-28iShares Russell 2000 ETF2.4190.0091466247322470.0482
2024-02-29Columbia Acorn Inst1.67240.1551322350090786339.2058
2024-03-31Vanguard Institutional Extnd Mkt Idx Tr1.65580.00393191398139274077.4322
2023-10-13Pictet Biopharmaceutical Mother1.36570.47162632200105687967.0898
2024-02-29Fidelity Select Pharmaceuticals Port1.15490.2874222600000
2023-12-31JNL Multi-Manager Small Cap Growth A1.09320.124821070101053918100.0784
2024-03-28iShares Russell 2000 Value ETF0.93290.01841798083-1140-0.0634
2023-12-31M&G (ACS) Granahan US Sm Cp Gr GBPZ1AAcc0.89350.5452172209354511946.3153
2024-03-28iShares Biotechnology ETF0.74170.024142960100
2024-02-29Granahan US SMID Select I GBP Acc0.62911.0243121261676840.6377
2024-03-31State St Russell Sm/Mid Cp® Indx NL Cl C0.60890.0035117369353670084.2552
2024-01-31Fidelity Small Cap Index0.55270.0044106525000
2024-03-31Victory Small Cap Stock0.52830.14081018236838148.9696
2024-03-31Granahan Inv Mgt Sm-Cap Core Gr0.52790.57341017440830188.8844
2024-03-31Granahan SMID Select0.52050.74491003239-194648-16.2493
2024-03-31Vanguard Russell 2000 ETF0.36930.00971177732223082.7192
2024-03-31JPM Thematics Genetic Thrps C2 Acc USD0.33360.116264304400
2024-02-29Wanger Acorn0.31720.155261136917480340.0405
2024-02-29JPMorgan Small Cap Value I0.23820.0465459203-32047-6.5236
Total 19.69774.458237965991+5948505+15.7%

3.3. Insider Transactions

Insiders are holding 0.378% of the shares of Bluebird bio Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2024-02-05Andrew ObenshainSELL18790.9
2024-02-05Thomas J KlimaSELL27140.9
2024-01-05Andrew ObenshainSELL31621.43
2024-01-05Richard A ColvinSELL5971.42
2023-12-06Christopher KrawtschukSELL45264.52
2023-09-05Thomas J KlimaSELL9223.79
2023-08-10Andrew ObenshainSELL169293.54
2023-06-02Thomas J KlimaSELL41303.5

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Bluebird bio Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.923-0.9230%-5.089+451%-1.481+60%0.131-806%
Book Value Per Share--1.0191.0190%1.942-48%5.288-81%4.712-78%
Current Ratio--1.5561.5560%2.200-29%4.914-68%8.140-81%
Debt To Asset Ratio--0.6460.6460%0.370+75%0.334+93%0.263+145%
Debt To Equity Ratio--1.8261.8260%0.587+211%0.652+180%0.451+305%
Dividend Per Share----0%0.904-100%0.181-100%0.090-100%
Eps---1.383-1.3830%-4.251+207%-3.165+129%-2.018+46%
Free Cash Flow Per Share---1.900-1.9000%-3.417+80%-2.733+44%-1.723-9%
Free Cash Flow To Equity Per Share---1.618-1.6180%-3.905+141%-1.420-12%0.110-1565%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--6.584--------
Intrinsic Value_10Y_min---26.718--------
Intrinsic Value_1Y_max---1.212--------
Intrinsic Value_1Y_min---2.747--------
Intrinsic Value_3Y_max---2.216--------
Intrinsic Value_3Y_min---8.242--------
Intrinsic Value_5Y_max---1.499--------
Intrinsic Value_5Y_min---13.682--------
Market Cap196596840.000-578%1333774640.0001333774640.0000%1925492580.000-31%9522063864.720-86%12788990651.800-90%
Net Profit Margin---74.111-74.1110%-153.642+107%-51.615-30%-32.538-56%
Operating Margin---79.814-79.8140%-161.363+102%-54.510-32%-34.196-57%
Operating Ratio--79.44179.4410%155.317-49%53.775+48%38.898+104%
Pb Ratio1.001-578%6.7936.7930%5.145+32%8.277-18%15.335-56%
Pe Ratio-0.737+85%-5.003-5.0030%-2.350-53%-15.326+206%-82.052+1540%
Price Per Share1.020-578%6.9206.9200%9.990-31%49.403-86%66.353-90%
Price To Free Cash Flow Ratio-0.537+85%-3.643-3.6430%-2.923-20%-18.076+396%-50.767+1294%
Price To Total Gains Ratio-1.105+85%-7.496-7.4960%-2.387-68%30.793-124%93.287-108%
Quick Ratio--2.0262.0260%3.571-43%8.977-77%12.415-84%
Return On Assets---0.480-0.4800%-0.948+97%-0.496+3%-0.326-32%
Return On Equity---1.358-1.3580%-1.503+11%-0.845-38%-0.520-62%
Total Gains Per Share---0.923-0.9230%-4.184+353%-1.300+41%0.221-517%
Usd Book Value--196343000.000196343000.0000%374277000.000-48%1019147800.000-81%908203100.000-78%
Usd Book Value Change Per Share---0.923-0.9230%-5.089+451%-1.481+60%0.131-806%
Usd Book Value Per Share--1.0191.0190%1.942-48%5.288-81%4.712-78%
Usd Dividend Per Share----0%0.904-100%0.181-100%0.090-100%
Usd Eps---1.383-1.3830%-4.251+207%-3.165+129%-2.018+46%
Usd Free Cash Flow---366161000.000-366161000.0000%-658642000.000+80%-526787800.000+44%-332148100.000-9%
Usd Free Cash Flow Per Share---1.900-1.9000%-3.417+80%-2.733+44%-1.723-9%
Usd Free Cash Flow To Equity Per Share---1.618-1.6180%-3.905+141%-1.420-12%0.110-1565%
Usd Market Cap196596840.000-578%1333774640.0001333774640.0000%1925492580.000-31%9522063864.720-86%12788990651.800-90%
Usd Price Per Share1.020-578%6.9206.9200%9.990-31%49.403-86%66.353-90%
Usd Profit---266578000.000-266578000.0000%-562638000.000+111%-558628800.000+110%-363310700.000+36%
Usd Revenue--3597000.0003597000.0000%3662000.000-2%71449200.000-95%45850900.000-92%
Usd Total Gains Per Share---0.923-0.9230%-4.184+353%-1.300+41%0.221-517%
 EOD+3 -5MRQTTM+0 -0YOY+20 -155Y+13 -2210Y+5 -30

4.2. Fundamental Score

Let's check the fundamental score of Bluebird bio Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-0.737
Price to Book Ratio (EOD)Between0-11.001
Net Profit Margin (MRQ)Greater than0-74.111
Operating Margin (MRQ)Greater than0-79.814
Quick Ratio (MRQ)Greater than12.026
Current Ratio (MRQ)Greater than11.556
Debt to Asset Ratio (MRQ)Less than10.646
Debt to Equity Ratio (MRQ)Less than11.826
Return on Equity (MRQ)Greater than0.15-1.358
Return on Assets (MRQ)Greater than0.05-0.480
Total3/10 (30.0%)

4.3. Technical Score

Let's check the technical score of Bluebird bio Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5048.276
Ma 20Greater thanMa 500.967
Ma 50Greater thanMa 1001.187
Ma 100Greater thanMa 2001.246
OpenGreater thanClose1.070
Total1/5 (20.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2018-12-312019-12-312020-12-312021-12-312022-12-31
Net Debt  -247,836111,609-136,22711,543-124,68453,108-71,576239,960168,384



Latest Balance Sheet

Balance Sheet of 2022-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets554,902
Total Liabilities358,559
Total Stockholder Equity196,343
 As reported
Total Liabilities 358,559
Total Stockholder Equity+ 196,343
Total Assets = 554,902

Assets

Total Assets554,902
Total Current Assets199,488
Long-term Assets355,414
Total Current Assets
Cash And Cash Equivalents 113,006
Short-term Investments 67,321
Net Receivables 10,787
Other Current Assets 8,374
Total Current Assets  (as reported)199,488
Total Current Assets  (calculated)199,488
+/-0
Long-term Assets
Property Plant Equipment 291,358
Goodwill 5,646
Long Term Investments 1,414
Intangible Assets 4,868
Other Assets 52,128
Long-term Assets  (as reported)355,414
Long-term Assets  (calculated)355,414
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities128,237
Long-term Liabilities230,322
Total Stockholder Equity196,343
Total Current Liabilities
Short-term Debt 51,160
Accounts payable 25,092
Other Current Liabilities 50,483
Total Current Liabilities  (as reported)128,237
Total Current Liabilities  (calculated)126,735
+/- 1,502
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt230,230
Long-term Liabilities Other 92
Long-term Liabilities  (as reported)230,322
Long-term Liabilities  (calculated)230,322
+/-0
Total Stockholder Equity
Common Stock830
Retained Earnings -3,986,503
Accumulated Other Comprehensive Income -4,070
Other Stockholders Equity 4,186,086
Total Stockholder Equity (as reported)196,343
Total Stockholder Equity (calculated)196,343
+/-0
Other
Capital Stock830
Cash and Short Term Investments 181,741
Common Stock Shares Outstanding 78,585
Current Deferred Revenue1,502
Liabilities and Stockholders Equity 554,902
Net Debt 168,384
Net Invested Capital 196,343
Net Tangible Assets 185,829
Net Working Capital 71,251
Property Plant and Equipment Gross 313,290
Short Long Term Debt Total 281,390



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-31
> Total Assets 
30,918
69,322
224,390
556,739
1,002,337
1,118,122
1,900,567
2,242,844
1,727,424
1,781,252
593,795
554,902
554,902593,7951,781,2521,727,4242,242,8441,900,5671,118,1221,002,337556,739224,39069,32230,918
   > Total Current Assets 
29,980
67,784
211,987
479,989
523,965
724,214
1,614,302
1,418,997
1,152,174
1,215,537
336,520
199,488
199,488336,5201,215,5371,152,1741,418,9971,614,302724,214523,965479,989211,98767,78429,980
       Cash And Cash Equivalents 
25,604
67,011
206,279
347,845
164,269
278,887
758,505
402,579
327,214
317,705
161,160
113,006
113,006161,160317,705327,214402,579758,505278,887164,269347,845206,27967,01125,604
       Short-term Investments 
3,507
0
0
125,710
353,680
425,491
531,604
982,725
779,246
833,546
138,343
67,321
67,321138,343833,546779,246982,725531,604425,491353,680125,710003,507
       Net Receivables 
0
0
693
1,913
0
8,542
3,112
13,931
12,826
26,814
11,389
10,787
10,78711,38926,81412,82613,9313,1128,54201,91369300
       Other Current Assets 
869
773
5,708
6,434
6,016
19,836
8,377
19,762
45,714
64,286
37,017
8,374
8,37437,01764,28645,71419,7628,37719,8366,0166,4345,708773869
   > Long-term Assets 
938
1,538
12,403
76,750
478,372
393,908
286,265
823,847
575,250
565,715
257,275
355,414
355,414257,275565,715575,250823,847286,265393,908478,37276,75012,4031,538938
       Property Plant Equipment 
728
1,288
10,920
15,740
82,614
156,955
199,606
246,622
337,061
346,850
101,238
291,358
291,358101,238346,850337,061246,622199,606156,95582,61415,74010,9201,288728
       Goodwill 
0
0
0
13,128
13,128
13,128
13,128
13,128
13,128
13,128
5,646
5,646
5,6465,64613,12813,12813,12813,12813,12813,12813,128000
       Long Term Investments 
0
0
0
18,448
347,814
180,452
324,193
506,123
131,506
122,891
97,114
1,414
1,41497,114122,891131,506506,123324,193180,452347,81418,448000
       Intangible Assets 
0
0
0
28,219
24,456
20,694
16,931
13,169
14,326
10,041
5,644
4,868
4,8685,64410,04114,32613,16916,93120,69424,45628,219000
       Other Assets 
210
250
1,483
1,215
10,360
22,679
23,940
44,805
79,229
72,805
53,277
52,128
52,12853,27772,80579,22944,80523,94022,67910,3601,2151,483250210
> Total Liabilities 
86,625
125,069
72,723
65,482
151,841
248,682
277,135
357,774
442,431
426,196
219,518
358,559
358,559219,518426,196442,431357,774277,135248,682151,84165,48272,723125,06986,625
   > Total Current Liabilities 
2,893
4,628
34,874
42,978
40,368
74,533
95,612
146,431
223,580
203,588
152,993
128,237
128,237152,993203,588223,580146,43195,61274,53340,36842,97834,8744,6282,893
       Short-term Debt 
653
1,599
4,902
14,174
24,561
50,181
1,051
1,424
20,175
25,024
23,152
51,160
51,16023,15225,02420,1751,4241,05150,18124,56114,1744,9021,599653
       Short Long Term Debt 
0
0
0
0
61,901
120,140
155,800
0
0
0
0
0
00000155,800120,14061,9010000
       Accounts payable 
1,793
2,173
4,359
2,954
6,334
13,664
12,873
17,831
42,995
21,602
25,883
25,092
25,09225,88321,60242,99517,83112,87313,6646,3342,9544,3592,1731,793
       Other Current Liabilities 
107
516
273
475
3,584
4,479
56,014
97,969
141,556
145,406
101,676
50,483
50,483101,676145,406141,55697,96956,0144,4793,584475273516107
   > Long-term Liabilities 
83,732
120,441
37,849
22,504
111,473
174,149
181,523
211,343
218,851
222,608
66,525
230,322
230,32266,525222,608218,851211,343181,523174,149111,47322,50437,849120,44183,732
       Long term Debt Total 
0
0
0
0
61,901
120,140
154,749
153,319
0
0
0
0
0000153,319154,749120,14061,9010000
       Other Liabilities 
1,329
601
37,156
20,591
49,572
54,009
26,774
58,024
48,039
54,611
93
0
09354,61148,03958,02426,77454,00949,57220,59137,1566011,329
       Deferred Long Term Liability 
0
0
37,641
15,889
44,253
50,612
24,483
0
0
0
0
0
0000024,48350,61244,25315,88937,64100
> Total Stockholder Equity
-55,707
-55,747
151,667
491,257
850,496
869,440
1,623,432
1,885,070
1,284,993
1,355,056
374,277
196,343
196,343374,2771,355,0561,284,9931,885,0701,623,432869,440850,496491,257151,667-55,747-55,707
   Common Stock
2
3
239
323
369
407
494
547
554
665
711
830
83071166555454749440736932323932
   Retained Earnings -3,986,503-3,719,925-2,900,547-2,281,852-1,498,808-913,808-577,674-314,167-147,384-98,675-73,354-63,442
   Accumulated Other Comprehensive Income 
1
-527
-1,454
-71
-2,291
-1,149
-4,205
-3,627
-1,893
-5,505
-2,911
-4,070
-4,070-2,911-5,505-1,893-3,627-4,205-1,149-2,291-71-1,454-5271
   Capital Surplus 
0
0
250,103
638,389
1,166,585
1,447,856
2,540,951
3,386,958
3,568,184
4,260,443
4,096,402
0
04,096,4024,260,4433,568,1843,386,9582,540,9511,447,8561,166,585638,389250,10300
   Treasury Stock000000000000
   Other Stockholders Equity 
7,732
15,267
27,167
638,389
1,166,585
1,447,856
2,540,951
3,386,958
3,568,184
4,260,443
4,096,402
4,186,086
4,186,0864,096,4024,260,4433,568,1843,386,9582,540,9511,447,8561,166,585638,38927,16715,2677,732



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue21,726
Cost of Revenue-23,916
Gross Profit-2,190-2,190
 
Operating Income (+$)
Gross Profit-2,190
Operating Expense-157,880
Operating Income-136,154-160,070
 
Operating Expense (+$)
Research Development179,781
Selling General Administrative149,113
Selling And Marketing Expenses-
Operating Expense157,880328,894
 
Net Interest Income (+$)
Interest Income8,327
Interest Expense--
Other Finance Cost-0
Net Interest Income8,327
 
Pretax Income (+$)
Operating Income-136,154
Net Interest Income8,327
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-91,137-172,844
EBIT - interestExpense = 0
-91,167
-91,167
Interest Expense-
Earnings Before Interest and Taxes (EBIT)--91,137
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax-91,137
Tax Provision-30
Net Income From Continuing Ops-91,167-91,167
Net Income-91,167
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net36,690-8,327
 

Technical Analysis of Bluebird bio Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Bluebird bio Inc. The general trend of Bluebird bio Inc is BEARISH with 85.7% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Bluebird bio Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-85.7%) Bearish trend (85.7%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Bluebird bio Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is -1/(-1 +1).

  • Around resistance: The price is trading arround resistance levels. This can be considered as a potential exit level. -1

The bullish price targets are: 1.07 < 1.3 < 1.6599.

The bearish price targets are: 0.879 > 0.8618.

Tweet this
Bluebird bio Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Bluebird bio Inc. The current mas is .

The long score for the Moving Averages is 1/14.
The longshort score for the Moving Averages is -12/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Bluebird bio Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Bluebird bio Inc. The current macd is -0.03955491.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Bluebird bio Inc price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Bluebird bio Inc. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Bluebird bio Inc price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Bluebird bio Inc Daily Moving Average Convergence/Divergence (MACD) ChartBluebird bio Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Bluebird bio Inc. The current adx is 18.79.

The long score for the Directional Movement Index (DMI) is 2/7.
The longshort score for the Directional Movement Index (DMI) is 2/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Bluebird bio Inc shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bullish trend could be forming. +1
Bluebird bio Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Bluebird bio Inc. The current sar is 0.89790026.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Bluebird bio Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Bluebird bio Inc. The current rsi is 48.28. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending down: The RSI is trending down. -1
Bluebird bio Inc Daily Relative Strength Index (RSI) ChartBluebird bio Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Bluebird bio Inc. The current phase is Continuation in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -4/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Bluebird bio Inc price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Bluebird bio Inc Daily Stochastic Oscillator ChartBluebird bio Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Bluebird bio Inc. The current cci is 94.80.

Bluebird bio Inc Daily Commodity Channel Index (CCI) ChartBluebird bio Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Bluebird bio Inc. The current cmo is 3.40083762.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Bluebird bio Inc Daily Chande Momentum Oscillator (CMO) ChartBluebird bio Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Bluebird bio Inc. The current willr is -57.03422053.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Bluebird bio Inc is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Bluebird bio Inc Daily Williams %R ChartBluebird bio Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Bluebird bio Inc.

Bluebird bio Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Bluebird bio Inc. The current atr is 0.11160296.

Bluebird bio Inc Daily Average True Range (ATR) ChartBluebird bio Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Bluebird bio Inc. The current obv is -3,448,942.

Bluebird bio Inc Daily On-Balance Volume (OBV) ChartBluebird bio Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Bluebird bio Inc. The current mfi is 46.91.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Bluebird bio Inc Daily Money Flow Index (MFI) ChartBluebird bio Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Bluebird bio Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-19ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-20BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-22STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-26STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-27RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-03STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-04STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-09STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-10MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-12WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-16STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-19CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-25RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-29RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-30STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-02MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-06STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-07MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-08RSI LONG ENTRY SHORT CLOSE30 crossover to upside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-09SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-02-13STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-16STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-20STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-22DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-02-23STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-26STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-27STOCH LONG EXITThe %K line crosses below the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-29ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-05SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-07STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-12CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-13CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-14MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-15STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-22STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-26DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-27DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-01CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-02DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-04-04DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-08STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-10STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-12DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-15BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-04-18STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-04-19MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-04-22STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-23SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-04-24SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-30STOCH LONG EXITThe %K line crosses below the %D line.
2024-05-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-05-03MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-05-07DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-05-08DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-05-09DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-05-10STOCH LONG EXITThe %K line crosses below the %D line.

6.3. Candlestick Patterns

Bluebird bio Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Bluebird bio Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5048.276
Ma 20Greater thanMa 500.967
Ma 50Greater thanMa 1001.187
Ma 100Greater thanMa 2001.246
OpenGreater thanClose1.070
Total1/5 (20.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Bluebird bio Inc with someone you think should read this too:
  • Are you bullish or bearish on Bluebird bio Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Bluebird bio Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Bluebird bio Inc

I send you an email if I find something interesting about Bluebird bio Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Bluebird bio Inc.

Receive notifications about Bluebird bio Inc in your mailbox!